The Theophylline Extended-Release Ta, cataloged under National Stock Number 6505-01-037-5613, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Inwood Laboratories Inc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 4 items share a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-037-5613 |
| Primary Part Number | NDC00258-3584-01 |
| Item Name | Theophylline Extended-Release Ta |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Inwood Laboratories Inc |
| Status | ACTIVE |
| Therapeutic Equivalent | THEO-DUR BY SCHERING |
| Primary Container Content Quantity | 100.000 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC50111-0483-01 | Sidmak Laboratories Inc (USA) |
| NDC00258-3584-01 | Forest Pharmaceuticals Inc Sub of Forest Laboratories Inc (USA) |
| NDC00258-3584-01 PRIMARY | Inwood Laboratories Inc (USA) |
| Reference | Meaning |
|---|---|
| THEO-DUR | 5/9 Secondary reference Schering-Plough Corporation |
| THEO-DUR TABLETS | 5/9 Secondary reference Schering-Plough Corporation |
| NDC00085-0487-01 | 5/9 Secondary reference Schering-Plough Corporation |
NSN 6505-01-037-5613 is a Theophylline Extended-Release Ta, manufactured by Inwood Laboratories Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-037-5613 has 3 manufacturer part numbers on file: NDC50111-0483-01 (Sidmak Laboratories Inc), NDC00258-3584-01 (Forest Pharmaceuticals Inc Sub of Forest Laboratories Inc), NDC00258-3584-01 (Inwood Laboratories Inc).
4 possible matches (shared part number, not a government interchangeability claim): 6505-01-070-0821, 6505-01-073-1552, 6505-01-093-9476. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00258-3584-01: Therapeutic Equivalent: THEO-DUR BY SCHERING; Primary Container Content Quantity: 100.000 TABLETS; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: THEOPHYLLINE EXTENDED-RELEASE TABLETS 100MG 100S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.